Málaga, Spain

Francisco Javier Pavón Morón

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Francisco Javier Pavón Morón: Innovator in Fatty Acid Amides

Introduction

Francisco Javier Pavón Morón is a notable inventor based in Málaga, Spain. He has made significant contributions to the field of biomedical research, particularly in the prevention and treatment of liver diseases. His innovative work has led to the development of a patent that addresses critical health issues related to fatty liver conditions.

Latest Patents

Pavón Morón holds a patent for "Fatty acid amides for the prevention and/or treatment of steatohepatitis." This invention focuses on the use of fatty acid amides combined with phenylalkylamines. The pharmaceutical composition developed by Pavón Morón aims to prevent and treat fatty liver diseases, including both alcoholic and non-alcoholic steatohepatitis (NASH). His work is crucial in addressing the growing health concerns associated with these conditions.

Career Highlights

Throughout his career, Francisco Javier Pavón Morón has been associated with prominent research institutions. He has worked with the Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (Fimabis) and the Consejo Superior de Investigaciones Científicas. His dedication to research and innovation has positioned him as a key figure in the biomedical field.

Collaborations

Pavón Morón has collaborated with esteemed colleagues, including Fernando Rodríguez De Fonseca and Juan Manuel Decara Del Olmo. These partnerships have enhanced his research efforts and contributed to the advancement of knowledge in the treatment of liver diseases.

Conclusion

Francisco Javier Pavón Morón is a distinguished inventor whose work in fatty acid amides has the potential to significantly impact the treatment of steatohepatitis. His contributions to biomedical research reflect his commitment to improving health outcomes for individuals affected by liver diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…